由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Pharmaceutical版 - Lilly中国研发中心开张只一年, 已有scientist盗窃数据被告
相关主题
Eli Lilly offer -- need help on negotiation.最近开始找工作,发现大药厂都不办H1啊
guest editor机会, Medicinal Chemistry在公司R&D做博士后的工资?
新人报道how to get the chem structure of a drug candidate quickly?
拿到一个药物公司的postdoc的位子 (转载)Eli Lilly and Company (LLY) And OSI Pharmaceuticals, Inc. (OSIP) Announce Licensing Agreement
请教:工作了的有机合成master简历该怎么update新人报道--大家多关照
受打击了!如果找工作的时候,简历上写
问:分子生物学博士毕业想进公司 (转载)进大公司好还是小公司好?
AbbottEli Lilly 好像不给博士一下学位的外国人办h1B?
相关话题的讨论汇总
话题: lilly话题: employee话题: former话题: our
进入Pharmaceutical版参与讨论
1 (共1页)
b**y
发帖数: 86
1
摘要:
Lilly goes to court over acts of former employee
• An employee of our Lilly China Research and Development facility
violated Lilly policy by downloading confidential business records to a non-
company storage device (example: an unencrypted USB thumb drive).
• The employee, who has since left the company, refused to return
the confidential information. That prompted Lilly to file legal action in
the Chinese courts to recover the company’s confidential business records
and protect them against possible disclosure to third parties.
• The stolen information and data are important—including
intellectual property, trade secrets, and confidential information. But
while serious, this incident does not raise a material concern at this time.
• Senior Vice President and General Counsel Mike Harrington
explains what harm was caused by the former employee’s actions and adds, "
Let’s be clear. Our intellectual property is the foundation of our work to
discover and develop innovative medicines, and we will pursue every legal
remedy to protect it."
full articles:
Lilly goes to court over acts of former employee
Lilly is asking the Chinese court system to order recovery of company
confidential business records that were inappropriately downloaded to a non-
company storage device (example: an unencrypted USB thumb drive) by a
research employee.
The employee, who has since left the company, has refused to return the
confidential records or to cooperate with Lilly’s investigation. At issue
is proprietary information relating to our scientific research.
With the confidential information still at risk, Lilly this week filed the
legal action in China that would:
• Require the former employee to return/delete company files.
• Require the former employee to identify any persons with whom he
has shared the information.
• Direct the former employee to not further use, disclose, or
transmit the company files to a third party.
"Obviously, we’re terribly disappointed this has occurred," said Mike
Harrington, senior vice president and general counsel, "but let’s be clear:
Our intellectual property is the foundation of our work to discover and
develop innovative medicines, and we will pursue every legal remedy to
protect it. The improper use of our trade secrets is a betrayal of all Lilly
employees and, more importantly, the patients who are waiting for new
medicines."
The former employee, a scientist, was hired to become one of approximately
150 employees at Lilly China Research and Development Center (LCRDC), which
officially opened in late May 2012.
Bei Betty Zhang, Ph.D., vice president of China research and the center's
site head and general manager, said she is "appalled and saddened" by the
former employee’s acts. "We are proud of the innovative research we’re
conducting to address the needs of the Chinese people, as well as the
dedication and diligence of our team," Zhang said. "It is difficult for us
here at LCRDC to learn such news about a former colleague."
The former employee had agreed to respect company confidentiality as a
condition of employment with Lilly.
Damaging consequences
This incident is not typical conduct by the overwhelming majority of
employees, Harrington said. He added that the issue of data theft is not
unique to China and could happen anywhere in the world.
"Protecting our intellectual property has long been a sacred trust for Lilly
innovators," Harrington said. Even a single instance of violating that
trust is "an unfortunate reminder of problems that can be caused by not
safeguarding confidential information that is essential for the success of
companies like Lilly."
Because of the former employee’s actions:
• A comprehensive evaluation had to be conducted to determine the
level of sensitivity of materials exposed outside Lilly’s secure computer
network and to resolve patent-related questions.
• Unscheduled expenses were incurred and important projects set
aside as a lawyer worked full-time on the matter, supported by scientists
diverted from pipeline priorities.
The former employee’s refusal to cooperate with the company led to Lilly’s
pursuit of legal action.
The stolen information and data are important—including intellectual
property, trade secrets, and other confidential information. But while
serious, this incident does not raise a material concern at this time.
l*u
发帖数: 2090
2


facility
non-

【在 b**y 的大作中提到】
: 摘要:
: Lilly goes to court over acts of former employee
: • An employee of our Lilly China Research and Development facility
: violated Lilly policy by downloading confidential business records to a non-
: company storage device (example: an unencrypted USB thumb drive).
: • The employee, who has since left the company, refused to return
: the confidential information. That prompted Lilly to file legal action in
: the Chinese courts to recover the company’s confidential business records
: and protect them against possible disclosure to third parties.
: • The stolen information and data are important—including

c*******g
发帖数: 695
3
大概2010年左右和一个lily level比较高的校友聊天
我问他:lily准备在中国搞研发中心么
他答:中国知识产权保护很差,公司很担心
........
看来这个校友还是很有远见的

摘要:
Lilly goes to court over acts of former employee
• An employee of our Lilly China Research and Development facility
violated Lilly policy by downloading confidential business records to a non-
company storage device (example: an unencrypted USB thumb drive).
• The employee, who has since left the company, refused to return
the confidential information. That prompted Lilly to file legal action in
the Chinese courts to recover the company’s confidential business records
and protect them against possible disclosure to third parties.
• The stolen information and data are important—including
intellectual property, trade secrets, and confidential information. But
while serious, this incident does not raise a material concern at this time.
• Senior Vice President and General Counsel Mike Harrington
explains what harm was caused by the former employee’s actions and adds, "
Let’s be clear. Our intellectual property is the foundation of our work to
discover and develop innovative medicines, and we will pursue every legal
remedy to protect it."
full articles:
Lilly goes to court over acts of former employee
Lilly is asking the Chinese court system to order recovery of company
confidential business records that were inappropriately downloaded to a non-
company storage device (example: an unencrypted USB thumb drive) by a
research employee.
The employee, who has since left the company, has refused to return the
confidential records or to cooperate with Lilly’s investigation. At issue
is proprietary information relating to our scientific research.
With the confidential information still at risk, Lilly this week filed the
legal action in China that would:
• Require the former employee to return/delete company files.
• Require the former employee to identify any persons with whom he
has shared the information.
• Direct the former employee to not further use, disclose, or
transmit the company files to a third party.
"Obviously, we’re terribly disappointed this has occurred," said Mike
Harrington, senior vice president and general counsel, "but let’s be clear:
Our intellectual property is the foundation of our work to discover and
develop innovative medicines, and we will pursue every legal remedy to
protect it. The improper use of our trade secrets is a betrayal of all Lilly
employees and, more importantly, the patients who are waiting for new
medicines."
The former employee, a scientist, was hired to become one of approximately
150 employees at Lilly China Research and Development Center (LCRDC), which
officially opened in late May 2012.
Bei Betty Zhang, Ph.D., vice president of China research and the center's
site head and general manager, said she is "appalled and saddened" by the
former employee’s acts. "We are proud of the innovative research we’re
conducting to address the needs of the Chinese people, as well as the
dedication and diligence of our team," Zhang said. "It is difficult for us
here at LCRDC to learn such news about a former colleague."
The former employee had agreed to respect company confidentiality as a
condition of employment with Lilly.
Damaging consequences
This incident is not typical conduct by the overwhelming majority of
employees, Harrington said. He added that the issue of data theft is not
unique to China and could happen anywhere in the world.
"Protecting our intellectual property has long been a sacred trust for Lilly
innovators," Harrington said. Even a single instance of violating that
trust is "an unfortunate reminder of problems that can be caused by not
safeguarding confidential information that is essential for the success of
companies like Lilly."
Because of the former employee’s actions:
• A comprehensive evaluation had to be conducted to determine the
level of sensitivity of materials exposed outside Lilly’s secure computer
network and to resolve patent-related questions.
• Unscheduled expenses were incurred and important projects set
aside as a lawyer worked full-time on the matter, supported by scientists
diverted from pipeline priorities.
The former employee’s refusal to cooperate with the company led to Lilly’s
pursuit of legal action.
The stolen information and data are important—including intellectual
property, trade secrets, and other confidential information. But while
serious, this incident does not raise a material concern at this time.

【在 b**y 的大作中提到】
: 摘要:
: Lilly goes to court over acts of former employee
: • An employee of our Lilly China Research and Development facility
: violated Lilly policy by downloading confidential business records to a non-
: company storage device (example: an unencrypted USB thumb drive).
: • The employee, who has since left the company, refused to return
: the confidential information. That prompted Lilly to file legal action in
: the Chinese courts to recover the company’s confidential business records
: and protect them against possible disclosure to third parties.
: • The stolen information and data are important—including

H******9
发帖数: 8087
4
无语

facility
non-

【在 b**y 的大作中提到】
: 摘要:
: Lilly goes to court over acts of former employee
: • An employee of our Lilly China Research and Development facility
: violated Lilly policy by downloading confidential business records to a non-
: company storage device (example: an unencrypted USB thumb drive).
: • The employee, who has since left the company, refused to return
: the confidential information. That prompted Lilly to file legal action in
: the Chinese courts to recover the company’s confidential business records
: and protect them against possible disclosure to third parties.
: • The stolen information and data are important—including

1 (共1页)
进入Pharmaceutical版参与讨论
相关主题
Eli Lilly 好像不给博士一下学位的外国人办h1B?请教:工作了的有机合成master简历该怎么update
工作offer选择 (转载)受打击了!
大只要公司的post-doct fellow一般pay多少?问:分子生物学博士毕业想进公司 (转载)
请问市面上又没有‘口服胰岛素’卖?Abbott
Eli Lilly offer -- need help on negotiation.最近开始找工作,发现大药厂都不办H1啊
guest editor机会, Medicinal Chemistry在公司R&D做博士后的工资?
新人报道how to get the chem structure of a drug candidate quickly?
拿到一个药物公司的postdoc的位子 (转载)Eli Lilly and Company (LLY) And OSI Pharmaceuticals, Inc. (OSIP) Announce Licensing Agreement
相关话题的讨论汇总
话题: lilly话题: employee话题: former话题: our